应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
08049 吉林长龙药业
休市中 08-14 14:31:10
2.235
-0.085
-3.66%
最高
2.280
最低
2.235
成交量
7.60万
今开
2.280
昨收
2.320
日振幅
1.94%
总市值
12.52亿
流通市值
3.86亿
总股本
5.60亿
成交额
17.25万
换手率
0.04%
流通股本
1.73亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
吉林长龙药业2026年中期业绩:营收4.35亿元,净利润1.23亿元
公告速递 · 08-14 22:32
吉林长龙药业2026年中期业绩:营收4.35亿元,净利润1.23亿元
吉林长龙药业(08049)披露2026年中期业绩:营收4.35亿元 净利润1.23亿元同比增19%
公告速递 · 08-14 22:31
吉林长龙药业(08049)披露2026年中期业绩:营收4.35亿元 净利润1.23亿元同比增19%
吉林长龙药业(08049)发布中期业绩,股东应占溢利1.23亿元 同比增加19.25%
智通财经 · 08-14 22:30
吉林长龙药业(08049)发布中期业绩,股东应占溢利1.23亿元 同比增加19.25%
吉林长龙药业拟于8月14日召开董事会审议2026年中期业绩
公告速递 · 08-04
吉林长龙药业拟于8月14日召开董事会审议2026年中期业绩
吉林长龙药业公布2026年7月股份变动月报表,股本维持稳定
公告速递 · 08-04
吉林长龙药业公布2026年7月股份变动月报表,股本维持稳定
吉林长龙药业发布2026年6月股份变动月报表,股本保持稳定
公告速递 · 07-03
吉林长龙药业发布2026年6月股份变动月报表,股本保持稳定
吉林长龙药业(08049)将于7月10日派发特别股息每股0.25元
智通财经 · 06-09
吉林长龙药业(08049)将于7月10日派发特别股息每股0.25元
吉林长龙药业建议派发特别股息每股0.25元,待股东大会批准
公告速递 · 06-09
吉林长龙药业建议派发特别股息每股0.25元,待股东大会批准
吉林长龙药业5月股份变动月报表:股本维持稳定
公告速递 · 06-02
吉林长龙药业5月股份变动月报表:股本维持稳定
吉林长龙药业2026年4月未有新增发行或股份变动
公告速递 · 05-05
吉林长龙药业2026年4月未有新增发行或股份变动
吉林长龙药业(08049)将于7月10日派发特别股息每股0.25元
智通财经 · 04-27
吉林长龙药业(08049)将于7月10日派发特别股息每股0.25元
吉林长龙药业将于2026年7月10日派发特别股息每股0.25元
公告速递 · 04-27
吉林长龙药业将于2026年7月10日派发特别股息每股0.25元
吉林长龙药业将于2026年06月09日派发特别股息每股0.25元
公告速递 · 04-24
吉林长龙药业将于2026年06月09日派发特别股息每股0.25元
吉林长龙药业将于2026年04月24日派发特别股息每股金额待定
公告速递 · 04-14
吉林长龙药业将于2026年04月24日派发特别股息每股金额待定
吉林长龙药业3月无新增发行或股份变动
公告速递 · 04-02
吉林长龙药业3月无新增发行或股份变动
吉林长龙药业(08049)公布2025年业绩 净利约1.99亿元 同比增长7.94%
智通财经 · 04-01
吉林长龙药业(08049)公布2025年业绩 净利约1.99亿元 同比增长7.94%
吉林长龙药业(08049)2025年营收突破9亿元,净利润稳步上升并强化核心产品布局
公告速递 · 03-31
吉林长龙药业(08049)2025年营收突破9亿元,净利润稳步上升并强化核心产品布局
吉林长龙药业盘中异动 下午盘快速跳水5.74%报1.970港元
市场透视 · 03-03
吉林长龙药业盘中异动 下午盘快速跳水5.74%报1.970港元
辉南长龙(08049)2月无新增发行或股份变动
公告速递 · 03-02
辉南长龙(08049)2月无新增发行或股份变动
吉林长龙药业盘中异动 下午盘股价大涨5.39%报2.150港元
市场透视 · 02-27
吉林长龙药业盘中异动 下午盘股价大涨5.39%报2.150港元
加载更多
公司概况
公司名称:
吉林长龙药业
所属市场:
SEHK
上市日期:
--
主营业务:
吉林省辉南长龙生化药业股份有限公司是一家主要从事制造及分销中药及医药产品的中国公司。该公司主要以“长龙”和“清通”品牌销售其产品。该公司的主要产品包括海昆肾喜胶囊、小容量注射剂、冻干粉针剂、粉针剂、原料药、无菌原料药、固体制剂化药等。该公司还对理财产品进行短期投资。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"08049","market":"HK","secType":"STK","nameCN":"吉林长龙药业","latestPrice":2.235,"timestamp":1786689070615,"preClose":2.32,"halted":0,"volume":76000,"delay":0,"changeRate":-0.03663793103448275,"floatShares":172500000,"shares":560000000,"eps":0.355,"marketStatus":"休市中","change":-0.085,"latestTime":"08-14 14:31:10","open":2.28,"high":2.28,"low":2.235,"amount":172540,"amplitude":0.019397,"askPrice":2.32,"askSize":4000,"bidPrice":2.23,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":0.395038,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":7,"adr":0,"listingDate":990633600000,"exchange":"SEHK","adjPreClose":2.32,"dividendRate":0.128456,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":5.937499967529297,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08049","defaultTab":"news","newsList":[{"id":"1193127735","title":"吉林长龙药业2026年中期业绩:营收4.35亿元,净利润1.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193127735","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193127735?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:32","pubTimestamp":1786717979,"startTime":"0","endTime":"0","summary":"2026年中期财报显示,吉林长龙药业在截至2026年6月30日止六个月内实现营收约4.35亿元,较2025年同期的4.39亿元小幅下降0.1%。公司唯一业务板块为在中国生产和分销中药及医药产品,本期营收主要来源于药物销售。本期毛利由上一年同期的3.62亿元增长至3.65亿元,毛利率约为83.9%。期间费用方面,分销及销售成本约1.98亿元,同比下降2.58%,行政开支约0.43亿元,同比下降4.66%。经营溢利约1.52亿元,相比上一年同期的1.24亿元增长约22.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"吉林长龙药业2026年中期业绩:营收4.35亿元,净利润1.23亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115303410","title":"吉林长龙药业(08049)披露2026年中期业绩:营收4.35亿元 净利润1.23亿元同比增19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115303410","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115303410?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:31","pubTimestamp":1786717870,"startTime":"0","endTime":"0","summary":"期内,集团实现营业额4.35亿元,较2025年同期的4.39亿元减少0.1%。归属于公司股东的净利润为1.23亿元,较上年同期增加1,983.2万元。行政开支0.43亿元,低于上年同期的0.45亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659814724","title":"吉林长龙药业(08049)发布中期业绩,股东应占溢利1.23亿元 同比增加19.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659814724","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659814724?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:30","pubTimestamp":1786717829,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林长龙药业(08049)发布2026年中期业绩,该集团取得营业额4.36亿元,同比减少0.87%;公司股东应占溢利1.23亿元,同比增加19.25%;每股盈利21.92分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08049","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131200951","title":"吉林长龙药业拟于8月14日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1131200951","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131200951?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:15","pubTimestamp":1785842154,"startTime":"0","endTime":"0","summary":"吉林长龙药业(08049)8月4日公告,公司董事会将于2026年8月14日上午10时在中国吉林省通化市辉南县朝阳镇经济开发区召开会议。此次会议将重点审议以下事项:\n1. 审议及批准公司及其附属公司截至2026年6月30日止六个月的未经审核中期业绩,并批准其初稿以刊登于香港联合交易所有限公司网站。\n2. 审议派发中期股息(如有)。\n3. 审议是否暂时停止办理股份过户登记手续(如有需要)。\n4. 审议及批准其他事项(如有)。\n公告称,公司董事会确认本公告所载资料在各重大方面均属准确及完整,并将在香港联交所网站刊登不少于七天。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122035085","title":"吉林长龙药业公布2026年7月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1122035085","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122035085?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:22","pubTimestamp":1785835325,"startTime":"0","endTime":"0","summary":"吉林省辉南长龙生化药业股份有限公司于2026年8月4日发布截至2026年7月31日的股份变动月报表。本次月报显示,公司法定注册股本为人民币56,025,000元,较上月无变动;其中普通股H股数量172,500,000股,普通股内资股数量387,750,000股,两者均与上月持平。根据公告,当月未发生任何新增发行、购回、注销或库存股变动,H股及内资股数量均与6月底保持一致。公告由公司秘书奠世昌签署,显示吉林长龙药业当月整体股本状况保持稳定,未有新增发行及回购活动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166041391","title":"吉林长龙药业发布2026年6月股份变动月报表,股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1166041391","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166041391?lang=zh_cn&edition=full","pubTime":"2026-07-03 10:42","pubTimestamp":1783046578,"startTime":"0","endTime":"0","summary":"2026年7月3日,吉林省辉南长龙生化药业股份有限公司(股票代码:08049)公布2026年6月股份变动月报表,披露期为截至2026年6月30日。\n公告显示,截至报告期末,吉林长龙药业普通股H股共计172,500,000股,内资股387,750,000股,分别与上月底持平,注册股本合计人民币56,025,000元,未发生新增发行、购回或库藏股等变动,股本结构保持稳定。公司披露,截至报告期末,H股满足香港联交所规定的公众持股量要求。\n公司表示,本次公告事项已获得董事会正式授权,并完全遵守了香港联交所《上市规则》及其他相关法律法规。公告由公司秘书奠世昌签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642139464","title":"吉林长龙药业(08049)将于7月10日派发特别股息每股0.25元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642139464","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642139464?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:01","pubTimestamp":1781002863,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林长龙药业(08049)发布公告,该公司将于2026年7月10日派发特别股息每股0.25元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08049","BK4588","BK4585","VIG","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133021205","title":"吉林长龙药业建议派发特别股息每股0.25元,待股东大会批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1133021205","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133021205?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:52","pubTimestamp":1781002321,"startTime":"0","endTime":"0","summary":"吉林长龙药业(08049)发布公告,建议派发特别股息每股0.25元人民币,此方案尚待2026年6月9日召开的股东大会批准。\n按公告所示,每股股息按1.1492的汇率折算为0.2873港元。若方案获批,将定于2026年6月22日除净,凡于6月23日16:30前递交股份过户文件者,可获收取股息资格。股份过户登记将自2026年6月24日至6月26日暂停,权益登记日为6月26日,预计7月10日派付。\n根据相关税务安排,非居民企业(非中国内地登记地址)及个人股东均须按10%税率代扣代缴所得税。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉林长龙药业建议派发特别股息每股0.25元,待股东大会批准","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164865332","title":"吉林长龙药业5月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1164865332","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164865332?lang=zh_cn&edition=full","pubTime":"2026-06-02 13:56","pubTimestamp":1780379796,"startTime":"0","endTime":"0","summary":"吉林省辉南长龙生化药业股份有限公司于2026年6月2日发布截至2026年5月31日的股份变动月报表。报告期内,公司已发行普通股主要分为H股与内资股两类。其中H股数量为172,500,000股,面值每股人民币0.1元,注册股本为人民币17,250,000元;内资股数量为387,750,000股,面值每股人民币0.1元,注册股本为人民币38,775,000元。本月底公司法定/注册股本总额为人民币56,025,000元。目前公司确认已在报告期内遵守香港联交所《上市规则》及相关法律法规。本次公告由公司秘书奠世昌签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102234500","title":"吉林长龙药业2026年4月未有新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1102234500","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102234500?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:40","pubTimestamp":1777970437,"startTime":"0","endTime":"0","summary":"吉林长龙药业于2026年5月5日披露截至2026年4月30日的证券变动月报表。本次月报显示,公司在报告期内不存在新增发行、购回、注销或库藏股等变化,股本维持不变。报告期内,两类股份均保持在原有发行数量水平,不存在新发行或回购注销情况。报告显示,公司本月无股份期权、股权激励或任何其他发行协议的变动,亦不存在购回或注销事务。截至2026年4月底,公司股本结构维持稳定。公告由公司秘书奠世昌签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630933731","title":"吉林长龙药业(08049)将于7月10日派发特别股息每股0.25元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630933731","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630933731?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:24","pubTimestamp":1777249456,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林长龙药业(08049)发布公告,将于2026年7月10日派发特别股息每股0.25元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","VIG","BK1191","BK4588","08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112591866","title":"吉林长龙药业将于2026年7月10日派发特别股息每股0.25元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112591866","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112591866?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:05","pubTimestamp":1777248352,"startTime":"0","endTime":"0","summary":"吉林长龙药业(08049)于2026年4月24日发布公告,董事会宣派每股人民币0.25元的特别股息,尚待股东于2026年6月9日批准。公司预计在2026年7月10日派发股息,股息将按港元支付,具体金额及汇率有待公布。\n根据公告,股份除净日为2026年6月22日,股东如欲符合派息资格,需于2026年6月23日16:30前递交股份过户文件。公司将于2026年6月24日至6月26日暂停办理股份过户登记,记录日期定为2026年6月26日。\n公告显示,对于非中国内地登记地址的非居民企业股东和个人股东,股息税率均为10%。本次特别股息的具体支付安排以公司最终公告为准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉林长龙药业将于2026年7月10日派发特别股息每股0.25元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152261184","title":"吉林长龙药业将于2026年06月09日派发特别股息每股0.25元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152261184","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152261184?lang=zh_cn&edition=full","pubTime":"2026-04-24 23:01","pubTimestamp":1777042894,"startTime":"0","endTime":"0","summary":"吉林长龙药业(08049)\\n\\n董事会建议就以前财政年度派发每股人民币0.25元(含税)的特别股息,股息总额为人民币1.40亿元(140,062,500元)。该派息方案尚待股东于2026年06月09日召开的股东特别大会审议批准。\\n\\n根据公告,股息附权日为2026年06月18日,除权日为2026年06月22日。公司将于2026年06月24日至2026年06月26日(包括首尾两天)暂停办理股份过户登记,用以确认股息发放权益。持有H股的股东需于2026年06月23日16时30分前递交过户文件,完成登记后方可享有收取此次特别股息的资格。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉林长龙药业将于2026年06月09日派发特别股息每股0.25元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167788431","title":"吉林长龙药业将于2026年04月24日派发特别股息每股金额待定","url":"https://stock-news.laohu8.com/highlight/detail?id=1167788431","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167788431?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:26","pubTimestamp":1776158777,"startTime":"0","endTime":"0","summary":"吉林长龙药业于公告中披露,董事会将于2026年4月24日(星期五)上午十时在中国吉林省通化市辉南县朝阳镇经济开发区召开会议,审议并可能批准就以前财政年度宣派及派付特别股息。公告同时提示,董事会未必最终通过该特别股息,且派付需满足其他条件,敬请投资者注意相关风险。本次拟派付的为特别股息,具体金额及实际派发时间仍待董事会审议并最终决议。(本报道仅根据公司最新公告内容编写,不含任何对公司前景的主观判断或保证。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167776110","title":"吉林长龙药业3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1167776110","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167776110?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:52","pubTimestamp":1775119934,"startTime":"0","endTime":"0","summary":"吉林长龙药业于2026年4月2日发布截至2026年3月31日的月报表。报告显示,公司在此期间未有新增股票发行、购回或注销行为,股本结构保持不变。公司表示,截至3月末,所有股份均符合联交所规定的公众持股量要求,且并无期权、可换股债券或其他股权激励工具的变动。公告由公司秘书奠世昌签署并发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624793536","title":"吉林长龙药业(08049)公布2025年业绩 净利约1.99亿元 同比增长7.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624793536","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2624793536?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:28","pubTimestamp":1774974506,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林长龙药业(08049)公布2025年业绩,总收入约9.02亿元,同比增长2.35%;公司股权持有人应占溢利约1.99亿元,同比增长7.94%;每股基本盈利35.5分。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190541075","title":"吉林长龙药业(08049)2025年营收突破9亿元,净利润稳步上升并强化核心产品布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1190541075","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190541075?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:14","pubTimestamp":1774966464,"startTime":"0","endTime":"0","summary":"2025年度,吉林长龙药业收入同比增长2.3%至人民币9.02亿元,其中主要由中成药及注射剂类产品的稳健销售所带动,核心品种“海昆肾喜胶囊”继续在肾病及相关治疗领域保持较高市场占有率。公司销售成本从人民币1.96亿元下降至人民币1.44亿元,毛利率由77.8%提升至84.0%,反映出成本管控及产能优化的协同效益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616758820","title":"吉林长龙药业盘中异动 下午盘快速跳水5.74%报1.970港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616758820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616758820?lang=zh_cn&edition=full","pubTime":"2026-03-03 13:03","pubTimestamp":1772514191,"startTime":"0","endTime":"0","summary":"2026年03月03日下午盘13时03分,吉林长龙药业股票出现异动,股价大幅下挫5.74%。截至发稿,该股报1.970港元/股,成交量8万股,换手率0.05%,振幅3.83%。吉林长龙药业股票所在的中医药行业中,整体跌幅为0.03%。其相关个股中,现代中药集团、位元堂、健倍苗苗涨幅较大,振幅较大的相关个股有现代中药集团、位元堂、福森药业,振幅分别为20.16%、11.76%、9.26%。吉林长龙药业公司简介:本公司业务主要在中国制造及分销本集团长龙和神迪品牌生化药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030313031197a7c6c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030313031197a7c6c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08049","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127133913","title":"辉南长龙(08049)2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1127133913","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127133913?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:55","pubTimestamp":1772445306,"startTime":"0","endTime":"0","summary":"吉林省辉南长龙生化药业股份有限公司于2026年3月2日发布2026年2月股份变动月报表,显示其报告期内各类股份数量与注册股本均保持不变,未有新增发行、购回或注销股份活动。截至2026年2月28日,公司总注册股本合计人民币56,025,000元,所有股份均无库藏股变动。公司确认遵守香港联交所《上市规则》及相关法律法规的要求,并指出报告期内未发生任何期权、购回或新增发行变动。本次公告由公司秘书莫世昌签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08049"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614880060","title":"吉林长龙药业盘中异动 下午盘股价大涨5.39%报2.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614880060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614880060?lang=zh_cn&edition=full","pubTime":"2026-02-27 13:51","pubTimestamp":1772171462,"startTime":"0","endTime":"0","summary":"2026年02月27日下午盘13时51分,吉林长龙药业股票出现波动,股价快速拉升5.39%。截至发稿,该股报2.150港元/股,成交量6.4万股,换手率0.04%,振幅4.41%。资金方面,该股资金流入13.488万港元,流出0港元。吉林长龙药业股票所在的中医药行业中,整体跌幅为0.04%。其相关个股中,吉林长龙药业、神威药业、现代中药集团涨幅较大,振幅较大的相关个股有福森药业、现代中药集团、吉林长龙药业,振幅分别为6.14%、3.23%、2.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227135102a4ce737c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227135102a4ce737c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","08049"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jlchanglong.com","stockEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":-0.0609},{"period":"3month","weight":0.0653},{"period":"6month","weight":0.2396},{"period":"1year","weight":0.138},{"period":"ytd","weight":0.1485}],"compareEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.0177},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0546},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"吉林省辉南长龙生化药业股份有限公司是一家主要从事制造及分销中药及医药产品的中国公司。该公司主要以“长龙”和“清通”品牌销售其产品。该公司的主要产品包括海昆肾喜胶囊、小容量注射剂、冻干粉针剂、粉针剂、原料药、无菌原料药、固体制剂化药等。该公司还对理财产品进行短期投资。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.042979},{"month":2,"riseRate":0.56,"avgChangeRate":0.058779},{"month":3,"riseRate":0.44,"avgChangeRate":0.014681},{"month":4,"riseRate":0.56,"avgChangeRate":0.030968},{"month":5,"riseRate":0.52,"avgChangeRate":0.050888},{"month":6,"riseRate":0.423077,"avgChangeRate":-0.031897},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.005962},{"month":8,"riseRate":0.5,"avgChangeRate":-0.00551},{"month":9,"riseRate":0.32,"avgChangeRate":-0.034481},{"month":10,"riseRate":0.56,"avgChangeRate":0.022389},{"month":11,"riseRate":0.48,"avgChangeRate":0.024261},{"month":12,"riseRate":0.36,"avgChangeRate":-0.009907}],"exchange":"SEHK","name":"吉林长龙药业","nameEN":"JILIN CHANGLONG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉林长龙药业(08049)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉林长龙药业(08049)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉林长龙药业,08049,吉林长龙药业股票,吉林长龙药业股票老虎,吉林长龙药业股票老虎国际,吉林长龙药业行情,吉林长龙药业股票行情,吉林长龙药业股价,吉林长龙药业股市,吉林长龙药业股票价格,吉林长龙药业股票交易,吉林长龙药业股票购买,吉林长龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉林长龙药业(08049)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉林长龙药业(08049)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}